Rockefeller Capital Management L.P. Oncolytics Biotech Inc Transaction History

Rockefeller Capital Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	BUY	$2.32 - $4.11 $4,640 - $8,220	2,000 Added 56.5%	5,540 $21,000
Q3 2020 Nov 13, 2020	BUY	$1.58 - $2.15 $4,730 - $6,437	2,994 Added 548.35%	3,540 $5,000
Q2 2020 Aug 12, 2020	SELL	$1.33 - $2.76 $139 - $289	-105 Reduced 16.13%	546 $1,000
Q4 2019 Feb 07, 2020	BUY	$0.42 - $4.76 $273 - $3,098	651 New	651 $3,000

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $53.8M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.